It is widely utilized in clinical settings outside the United States for treating stroke victims, traumatic brain injuries (TBI), and early-onset Alzheimer's disease
DSIP is frequently researched for its relationship to sleep regulation pathways, circadian rhythm activity, neuroendocrine signaling, and recovery-related biological processes
Reported benefits (per available research): Studied for its ability to raise GH and IGF-1 toward youthful levels and blunt age-related loss of fat-free mass, based on a 2-year randomized, placebo-controlled trial in 65 healthy older adults (Nass et al., 2008, Annals of Internal Medicine, PMID 18981485)
The risk of off-target effects, immune system disruption, or toxicity when these agents are used in combination or over extended periods is still a significant challenge
The association between smoking and breast cancer characteristics and outcome